Twitter Logo Youtube Circle Icon LinkedIn Icon

Hong Kong > Capital markets > Capital markets (equity) > Law firm and leading lawyer rankings


Index of tables

  1. Capital markets (equity)
  2. Leading individuals
  3. Next Generation Partners

Leading individuals

  1. 1

Next Generation Partners

  1. 1
    • Aldo Chan - Norton Rose Fulbright
    • Donnelly Chan - Allen & Overy
    • Marjory Ding - Simpson Thacher & Bartlett LLP
    • Li Jiang - Ashurst
    • Doris Leung - Deacons
    • Vincent Wang - Paul Hastings LLP

Between 2012 and 2017, Clifford Chance handled 19 out of 35 Hong Kong IPOs where the offering size was circa $1bn or above. Amy Lo and Beijing-based Tim Wang jointly led a team that included Liu Fang, consultant Christine Xu and Lawrence Zhang in advice to the joint sponsors and underwriters (including Morgan Stanley, Bank of America Merrill Lynch and Credit Suisse) on China Literature's $1.1bn spin-off listing on the Hong Kong Stock Exchange. The firm has handled other high-profile listings, as was evidenced when Virginia Lee and others acted for the joint global coordinators in BOCOM International's $230m IPO and listing on the Hong Kong Stock Exchange; this matter represented the first listing of a securities brokerage business on the Hong Kong Stock Exchange by a PRC bank. Another highlight involved acting for the joint sponsors on Shandong International Trust's $378m IPO, the first-ever Hong Kong IPO of a Chinese trust company. The firm also has strong US law capabilities, encompassing SEC-registered offerings as well as Regulation S and Rule 144A deals; Fang was one of the lead advisers to the underwriters (led by Jefferies) on Secoo's $110.5m IPO and listing of American depositary shares on the Nasdaq Global Market. Complementing the firm's strong underwriter-side capabilities is its excellent work for corporates. Frank Yuen is another key figure in the team, which also advises clients on public takeovers and pre- and post-IPO fundraisings.

Davis Polk & Wardwell LLP's Hong Kong team has an outstanding track record in high-profile Hong Kong and US IPOs,: it is an equally strong performer in secondary capital markets transactions, providing notable regulatory expertise. Bonnie Chan, Li He and counsel Yang Chu recently acted for the underwriters on the $1.12bn Hong Kong IPO and listing of Ping An Healthcare and Technology (also known as Ping An Good Doctor). Also notable is that Li and James Lin advised Sunlands Online Education Group on its $149.5m IPO and listing on the New York Stock Exchange. In addition, Lin and counsel Terrence O’Donnell handled the $27.5m NASDAQ IPO by iClick Interactive Asia Group for the underwriters. China Everbright Greentech, Razer and Tencent Holdings are other key clients of the team, which also includes counsels Stephenie Fung and Bingqing Pan. Paul Chow is also recommended.

Since 2013, Freshfields Bruckhaus Deringer has advised on 49 Hong Kong IPOs, with a total market capitalisation of more than $200bn. The firm's excellent credentials in large, complex and often first-to-the-market listings are underpinned by its team's awareness of regulatory developments. Teresa Ko, who founded the firm's Asia equity capital markets practice, has more than 26 years of experience undertaking high-profile securities transactions for Chinese and international clients. Other notable individuals are Grace Huang and counsel Constance Chou, who acted for Sisram Medical on its $125m Hong Kong Stock Exchange IPO; this matter represented the first-ever listing by an Israeli issuer in Hong Kong. On the underwriter side, Calvin Lai, Ko and others advised HSBC, Huatai Securities and Morgan Stanley as joint global coordinators on A Living's spin-off from Agile Group, and on A-Living's separate listing on the Hong Kong Stock Exchange. Yixin Group, Hebei Construction and Inner Mongolia Energy Engineering are among the firm's recent client wins. The Hong Kong team works closely with Richard Wang and Jason Xu, who are both based in Beijing. David Ludwick relocated to the London office.

Kirkland & Ellis provides full-service support to clients on premium US and Hong Kong IPOs, and is also a first port of call for secondary offerings, share sales and take-private transactions. The team, which is jointly led by David Zhang and Li-Chien Wong, is always up speed with regulatory developments, owing to its engagements with regulatory bodies such as the SEC, SFC, Hong Stock Exchange and New York Stock Exchange. In 2017, Zhang co-led a cross-office team, which acted for the underwriters (Morgan Stanley, Credit Suisse, Citigroup, CICC and UBS) on Qudian's $1.04bn New York Stock Exchange IPO; this matter represented the largest listing by a Chinese fintech company in the US to date. In addition, Zhang and Ben James were among the advisers to Sea Limited on its $884m New York Stock Exchange listing. In the education sector, the team has also recently handled US listings for clients such as Four Seasons Education (Cayman) and Rise Education, and acted for the underwriters on the IPO and listing of RYB Education. Outside of the US, a highlight involved acting for CLSA Capital Markets (as sole sponsor) and CLSA (as sole global coordinator and bookrunner) in Vobile Group's HK$237m IPO and listing. Meng Ding has joined from Davis Polk & Wardwell LLP, while Wanda Woo is a recent addition from Shearman & Sterling.

Simpson Thacher & Bartlett LLP fields 'some of the best practitioners in the business'; its team is praised for its 'professionalism' and 'domain knowledge'. It was involved in two of the three largest US IPOs by Chinese companies in 2017; Chris Lin, Daniel Fertig and counsel David Lee advised Qudian on its $975.5m New York Stock Exchange IPO (this was the largest US IPO by a Chinese company in 2017, and the largest by a Chinese fintech company to date). In addition, Lin, Fertig and counsel Yi Gao acted for BEST Inc. on its $520m New York Stock Exchange IPO, which was the third-largest in the US by a Chinese company in 2017. The firm also assisted GreenTree Hospitality Group with its $142.8m New York Stock Exchange IPO, and acted for the underwriters (led by Morgan Stanley) on OneSmart Education's New York listing. Elsewhere, Christopher Wong and others have acted for issuers on a number of IPOs in Hong Kong, including for Zhenro Properties Group and Shandong International Trust. Follow-on offerings and offerings of global depositary shares are another mainstay of the firm's equity capital markets practice. In addition, the team has a notable specialism in Taiwan-related matters; the firm has completed more than 100 transactions involving Taiwan issuers since the early 1990s. Celia Lam and counsel Marjory Ding are also recommended.

Skadden, Arps, Slate, Meagher & Flom LLP's team is a regular fixture in big-ticket, landmark listings and other offerings. It was involved in three of the ten largest listings in Hong Kong in 2017, and has particularly made a name for itself in 'new economy' IPOs; Julie Gao, Christopher Betts, Will Cai and counsel Anthony Pang acted for ZhongAn Online P&C Insurance on its $1.53bn IPO of H shares; this was the first public offering of its kind for an internet-only insurer. Gao, Betts and others also  advised China Literature Limited on its spin-off from Tencent via a $1.06bn IPO and listing. In addition, the group advised Chinese online car retailer Yixin Group on its spin-off from Bitauto Holdings (China) via an $870m IPO. Another highlight saw Betts act as the lead adviser to China Education Group Holdings (Hong Kong) on its $430m IPO; this is the largest-ever education sector IPO in Hong Kong to date. The team also recently acted for Xiaomi on its circa $4.7bn Hong Kong listing. The firm is a powerhouse for IPOs and other offerings outside of Hong Kong, having advised on more than 70 NASDAQ and New York Stock Exchange IPOs by Asia-based private companies since 2003. It has featured in more than 60% of the US IPOs involving China-domiciled companies since 2009, and was issuers' counsel on most of those deals. In a recent matter, Gao and Cai acted for iQiyi on its $2.25bn IPO of American depositary shares and NASDAQ listing; this was the largest IPO out of Asia in the first quarter of 2018. Jonathan Stone, Edward Lam, and of counsels Antony Dapiran and Paloma Wang, are also highly recommended.

Allen & Overy demonstrates 'a clear commitment to ensuring the best possible outcome for its clients, delivered in a sensible and pragmatic way'. Its team, which is led by Lina Lee, is 'very responsive, hands-on, and most importantly, commercial'. The firm's practice has gone from strength to strength since it underwent a major overhaul of its equity capital markets practice in 2016; this saw Mandarin-speaking US securities partner Liang Tao join from Davis Polk & Wardwell LLP, and Lee and Jonathan Hsui arrive from Ashurst. In addition, Michael Jacobs relocated to the Hong Kong office from London in 2017 and, in a more recent development, Kung-Wei Liu joined as an of counsel from Sullivan & Cromwell. The strengthening of the team has enhanced the firm's market profile, and enabled it to increase its volume of high-quality mandates from issuer and underwriter clients, including Chinese and international bulge-bracket investment banks. Its recent mandates have spanned a wide variety of industries, particularly the TMT, education, life sciences and automotive sectors. Lee, Hsui and others have advised Morgan Stanley on a number of matters, including the placement of new shares by Hong Kong Stock Exchange-listed company China ZhengTong Auto Services.  In another matter, Lee and senior associate Sylvester Sung advised CIMB Securities as sponsor on the Hong Kong Stock Exchange listing of Xinghua Port Holdings (a spin-off of Singapore-listed Pan-United Corporation). Also notable is that Hsui, Tao and others acted for BNP Paribas, CITIC CLSA, ICBCI, CCBI and ABCI in the $435m Hong Kong IPO and listing of China Education Group. Other clients include Kingboard Chemical, Fosun International and China Medical System. Of counsel Donnelly Chan is a name to note.

Herbert Smith Freehills' practice in Greater China is headed by Matthew Emsley, who was recently appointed as a member of the Listing Committee of the Main Board and GEM of the Hong Kong Stock Exchange. Emsley's team provides the full spectrum of advice to clients (including financial institutions, as well as Chinese and international corporates) on cross-border IPOs, as well as other matters, such as rights issuances, placements and block trades. In addition to having resources in Hong Kong, the firm is also able to leverage the expertise of its wider network, where required. In 2017, Emsley, senior associate George Wu and Singapore-based US securities expert Siddhartha Sivaramakrishnan were among the advisers to China International Capital and CEB International Capital as underwriters on the $376m Hong Kong Stock Exchange IPO and spin-off listing of China Everbright Greentech. In the education sector, Emsley, Sivaramakrishnan and others acted for Macquarie Capital and Citigroup Global Markets Asia as underwriters and joint sponsors in the $178m listing of Minsheng Education Group on the Hong Kong Stock Exchange. Emsley's team also acted for the underwriters on other education sector listings in Hong Kong, including those involving China Xinhua Education Group and China New Higher Education Group. Pharmaceuticals, oil and gas, real estate and telecoms are among other areas of activity. In addition to acting for financial institutions, Jason Sung acts for Chinese state-owned enterprises and privately owned companies. The Hong Kong team also includes Tommy Tong, senior associate Charles Wang and senior assistant Stanley Xie. It also works closely with Tom Chau and Zhong Wang in Beijing.

Latham & Watkins LLP combines local law expertise with the resources of its international platform, putting it in high demand among issuers and underwriters for advice on their most challenging, big-ticket Hong Kong and US IPOs, and other equity offerings. The firm has more than two decades' experience of the Greater China market, and assists clients with the full range of issues from a Hong Kong, US and English law angle. A key figure at the firm is Cathy Yeung, who is global co-chair of the capital markets practice and also serves as chair of the Greater China practice. Illustrative of the firm's excellent reputation for assisting PRC banks with Hong Kong listings, Yeung worked alongside Allen Wang, recently promoted partner Terris Tang and others to act for Bank of Gansu on its HK$6bn IPO on the Hong Kong Stock Exchange. In the public utilities sector, Yeung and Tang were the lead advisers to Kunming Dianchi Water Treatment, a Yunnan-based wastewater treatment and reclaimed water supplier, on its $171m Hong Kong Stock Exchange IPO of H shares. In the US, a notable highlight saw Wang lead a cross-office team that acted for the underwriters (including Citigroup Global Markets, Goldman Sachs and J.P. Morgan, among others) in BEST Inc's $450m IPO on the New York Stock Exchange. The team also acted for the underwriters (including Morgan Stanley, UBS and Bank of America Merrill Lynch) on GreenTree Hospitality Group's $143m IPO on the New York Stock Exchange. Other notable individuals include Amy Beckingham and Simon Cooke, who advised MBK Partners HK on a block trade of 34 million H shares on the Hong Kong Stock Exchange. Benjamin Su and Daying Zhang recently rejoined the firm from Kirkland & Ellis. Zheng Wang made counsel in 2017.

Led by Robert Cleaver, Linklaters' highly regarded team serves as a trusted adviser to corporates as well as bulge-bracket investment banks and other financial institutions on many of their most significant equity transactions. It provides local law and cross-border advice on all aspects of IPOs, rights issuances and open offers. Block trades are a particular area of strength for the group; at the time of writing, it had advised on 20 of the largest block trades in Hong Kong, with a collective value of more than $6bn. A notable individual is Iris Leung, who is dual-qualified in Hong Kong and US law, and has more than 13 years of experience advising corporates and financial institutions on major Asian and US capital markets transactions. Showcasing the firm's strengths in block trades, Leung acted for Morgan Stanley and Merrill Lynch as placing agents in a $650m sell-down of shares by WuXi Biologics Holdings of its 10.83% shareholding of the issued shares in WuXi Biologics (Cayman). Kevin Cheung and Gilbert Li jointly head up the firm's China desk. Li is particularly knowledgeable about the TMT, fintech, healthcare and biotech sectors, but also advises clients on matters involving other industries, as was illustrated when he acted for Deutsche Bank, Citigroup Global Markets and BOCI Asia (as placing agents) on China SCE Property's proposed $203m top-up placing in 2017. Another highlight saw Li, Cleaver and Leung advise Morgan Stanley as placing agent on the $292m issuance and placing of new H shares in Shanghai Fosun Pharmaceutical. Li more recently acted for Deutsche Bank as placing agent in Future Land Development Holdings' $198m top-up placing. Craig Dally is a thought-leader when it comes to the regulatory regime in Hong Kong, and has contributed to various regulatory initiatives, such as the Asia Securities Industry & Financial Markets Association (ASIFMA)'s reform of the block-trade launch process.

Norton Rose Fulbright's experienced team covers the full range of equity transactions for companies, international banks and Chinese underwriters. Off the back of changes to listing rules in Hong Kong, the group has been increasingly sought to advise technology and biotech companies in particular on their capital raising activities. It is also a go-to firm for transactions spanning a wide range of other industries, such as technology, financial services, consumer and real estate, and has excellent cross-border capabilities. Practice head Psyche Tai, Doris Ng, and Harold Tin are the key names to note. Winnie Chan, Emma de Ronde, Terence Lau and Vicky Lam are also recommended; Aldo Chan is a senior associate to note.

Paul Hastings LLP's prominence in the Hong Kong listings market is reflected by the fact that the matters it handled in 2017 accounted for 11% (circa $1.8bn) of funds raised across all IPOs in Hong Kong that year. Its practice also extends to IPOs and global offerings elsewhere in the Asia-Pacific region, including Malaysia, the Philippines and South Korea. It is also extremely active in the US. Further underlining the firm's reputation, it acts for many of the leading investment banks and other financial institutions, including Morgan Stanley, Credit Suisse, BOCI Asia and CIMB Investment Bank. Raymond Li, Zhaoyu Ren, Bonnie Yung and of counsel Vincent Wang were among the advisers to the joint sponsors (CMB International Capital, CCB International Capital, Huatai Financial Holdings (Hong Kong), Guotai Junan Capital and BOCI Asia) on Bank of Gansu's $761m Hong Kong IPO. Yung and of counsel Bonnie Kong were also part of a cross-office team that assisted SoftBank Vision Fund with its $550m investment into the $1.5bn Hong Kong IPO of ZhongAn Online Property and Casualty Insurance. On the issuer side, Li, Kong and others acted for New Focus Auto on its proposed issuance of new shares to two investors, raising circa $128m. Clients also benefit from the experience of Nan Li. Steven Winegar left to go in-house at Ping An Group.

Shearman & Sterling is highly rated by issuer and underwriter clients for high-profile and complex Hong Kong Stock Exchange, New York Stock Exchange and NASDAQ listings. Its team has increasingly become a first port of call for offerings in the healthcare, technology and real estate sectors. In 2017, global corporate finance head Matthew Bersani acted for Goldman Sachs, Bank of America Merrill Lynch, Deutsche Bank, China Renaissance and ICBCI on LexinFintech's $108m IPO and listing on the NASDAQ Global Market. In Hong Kong, Asia capital markets head Colin Law, Bersani and others advised Bank of America Merrill Lynch, Morgan Stanley and China Merchant Securities as joint sponsors, joint global coordinators and joint bookrunners on the $510m global offering and Main Board IPO of WuXi Biologics; this is only the second time a former US-listed company has relisted in Hong Kong. Law has also led the advice to WuXi Biologics on a series of block trades. Elsewhere, Peter Chen, counsel Edward Bong and others acted for Tianjin Tianbao Energy on the placing and IPO of its H shares on the Hong Kong Stock Exchange Main Board. Paloma Wang moved to Skadden, Arps, Slate, Meagher & Flom LLP.

Slaughter and May's team, which is led by John Moore and Benita Yu, has a first-rate reputation assisting issuers and underwriters with landmark equity capital markets transactions. The scope of its work is wide-ranging, including IPOs, secondary placings and post-listing M&A. The group’s ability to leverage Hong Kong, English and US law expertise is a notable value-add.

Sullivan & Cromwell established a presence in Hong Kong 25 years ago, and has since handled $84bn-worth of Hong Kong IPOs. Although the overwhelming majority of its work has tended to be for Greater China-based issuers, the firm also acts for clients located elsewhere in the Asia-Pacific region and in the US. In addition to handling standalone Hong Kong listings, the team is experienced in dual listings involving the Hong Kong Stock Exchange and Shanghai Stock Exchange, as well as dual listings involving the Hong Kong Stock Exchange and US-based stock exchanges. In a matter representing the largest Hong Kong IPO of a Chinese bank in 2017, Kay Ian Ng and Garth Bray were the lead advisers to the underwriters on Zhongyuan Bank's $1.19bn listing of H shares on the Hong Kong Stock Exchange and IPO. Other work included Ng, Bray, Ching-Yang Lin, and other members of a cross-office team advising the underwriters (with Goldman Sachs as the sole sponsor and global coordinator) on the Hong Kong and US law aspects of AK Medical Holdings' $64m global offering and Hong Kong Stock Exchange listing. Another highlight saw Chun Wei and others act for Bank of America Merrill Lynch as the sole global coordinator, bookrunner and underwriter on China Power International's $576m one-for-three rights issue.

At Ashurst, Stuart Rubin has worked on equity capital markets transactions involving every major listing venue globally, and is highly active in matters across Asia. Rubin has particularly strong relationships with a number of bulge-bracket investment banks, including Goldman Sachs and Bank of America Merrill Lynch. Rubin co-heads the practice with Frank Bi, a recent hire from Slaughter and May, whose arrival is seen as key to growing the firm's offering to China-facing issuers and sponsors. The practice has a particular focus on equity offerings and transactions that are linked to highly regulated and cutting-edge sectors, such as banking and financial services, biotech and pharmaceuticals, the digital economy, and energy and natural resources. In 2017, Rubin acted as special counsel to Nomura, as one of the bookrunning lead managers, on the $1.5bn Indian IPO of New India Assurance; this was the third-largest IPO in India ever. Another India-related matter saw Rubin and New York-qualified senior associate Li Jiang advise Citi as placing agent on a $1.38bn block trade of shares by Tata Consultancy Services. Rubin was also the lead adviser to UBS as a joint broker on a $510m block trade of shares in Bharti Infratel by Bharti subsidiary Nettle Infrastructure Investment. The Indonesian market has been another major source of work; a highlight for the firm involved Rubin acting as international legal counsel to the underwriters on the $95m Indonesian IPO of GMF Aero Asia. Other clients include Kotak Mahindra Bank, DBS and RHB.

In terms of deal volume, Deacons is one of the most active firms in the market for Hong Kong offerings. Between 2013 and 2017, it handled 70 completed IPOs and new listings, with the work spanning industries such as gaming, construction, healthcare and oil and gas. Its longstanding first-rate reputation has also seen it become a destination firm for secondary offerings and regulatory advice. The firm's full-service offering and depth of expertise have enabled it to become a trusted adviser to multinational and domestic corporates, as well as Chinese and international sponsors and underwriters. In 2017, a team including Ronny Chow, Rhoda Yung and Maynard Leung acted for The Wharf, Wheelock (Wharf's holding company) and Wharf Real Estate Investment Company (Wharf REIC) in Wharf REIC's spin-off and HK$151.8bn Main Board listing. On the underwriter side, Chow and Leung advised BNP Paribas Securities (Asia) as sole global coordinator, bookrunner and underwriter on a circa HK$2bn one-for-three rights issuance by TCL Multimedia Technology Holdings. Chow co-heads the practice with Eugina Chan. Another name to note is Sabrina Fung, who has more than 18 years of corporate finance experience, and acted for Huajin Securities (International) as one of the placing agents in a HK$1.4bn top-up placing by Jiayuan International Group. Also recommended are newly promoted partner Gary Wong, senior associate Veronica Hui  and associate Doris Leung. Peter Cheng joined from Davis Polk & Wardwell LLP.

DLA Piper's full-service offering is a major draw for clients, as is illustrated by the fact that more than 30 Hong Kong-listed companies turn to the firm for post-listings and compliance support in relation to the Hong Kong Listing Rules and Hong Kong Takeovers Code. Melody He-Chen, who heads the practice with Liu Wei, is US- and Hong Kong-qualified. Her experience includes acting for sponsors and companies on global offerings and Hong Kong Stock Exchange listings, rights issuances and share placings. Newly promoted partner Christina Loh co-led a cross-office team in advice to longstanding client Ping An Insurance (Group) as controlling shareholder on the $1.1bn listing of Ping An Healthcare and Technology (also known as Ping An Good Doctor) on the Hong Kong Stock Exchange; this was the largest Hong Kong IPO in the first quarter of 2018. Another high-profile mandate saw He-Chen, Loh, of counsel Janny Tai and Christine Chen act for China Merchants Securities as the sole sponsor, global coordinator and bookrunner on CSMall Group's circa HK$462m global offering and Hong Kong Main Board listing. In addition, Wei and Loh were the lead advisers to China Maple Leaf Educational Systems on its HK$1bn+ top-up placing of shares. The firm has also recently handled mandates for clients such as KGI Capital Asia, China Southern Airlines and Yestock. Henry Cheng joined from Kirkland & Ellis, while Mike Suen left to join Withers.

Hogan Lovells' equity capital markets practice in Asia has been growing, following the arrivals in 2016 of Sammy Li and Stephen Peepels from Paul Hastings LLP and DLA Piper respectively. In addition to working with other offices on multi-jurisdictional matters originated from the firm's wider network, the Hong Kong team has built up its own portfolio of cross-border work from clients in Greater China and the wider Asia-Pacific region. Li, Peepels and Nelson Tang jointly head up the team, which has become particularly active in emerging markets such as India, Indonesia and Vietnam. The firm has a strong client following on the institutional side; in 2017, Tang and senior associate Jeffrey Lee acted for RaffAello Capital as the sole sponsor and RaffAello Securities (HK) as the sole bookrunner and lead manager on the HK$79m Hong Kong GEM Board IPO of Fineland Real Estate Services Group. In addition, Lee was the lead adviser to the sole sponsor and the underwriters on the HK$70m Hong Kong IPO of restaurant group 1957 & Co. (Hospitality). A key differentiator of the firm's offering is its ability to leverage the network to assist issuers with the most complex aspects of their listings, where appropriate; Peepels has been working alongside members of the international trade and investment team in Washington DC in the advice to more than 20 companies on the applicability of US, EU, UN and Australian economic sanctions and export controls in the context of their Hong Kong IPOs. In addition to handling IPOs and secondary offerings, the team also acts for listed companies in corporate transactions, as was illustrated when Tang and Lee advised Hong Kong listed company Welling on its circa $237m privatisation by Midea by way of a scheme of arrangement.

King & Wood Mallesons provides support to Chinese companies on all aspects of their listing requirements, with its work spanning Hong Kong Main Board and GEM listings (including spin-off transactions), US listings and dual listings. Secondary offerings and public takeovers are among other pillars of the highly regarded practice, which is co-led by Sheldon Tse, Gary Lock and Candy Chan. The team also has strong client relationships with a number of Chinese investment banks, for which it leverages its extensive knowledge about the Chinese legal and regulatory environment to cover various issues. Acting as PRC, Hong Kong and US counsel, Chan and Christine Chen were part of the team that advised Guangzhou Rural Commercial Bank on its HK$9.28bn Hong Kong Main Board IPO; this was one of the largest listings in Hong Kong in 2017. In a more recent matter, Tse, Chen and senior associate Sheryl Cheung acted as Hong Kong counsel to China Boqi Environmental Holdings on its circa HK$605m global offering and Hong Kong Main Board listing. A notable underwriter-side mandate involved acting as Hong Kong counsel to SPDB International Capital as sole sponsor on the circa HK$147m Hong Kong Main Board IPO by PRC-based Putian Communication Group. Other clients include Zhongyuan Bank, Persta Resources and BOCOM International Holdings. Anthony Wan and John Baptist Chan are also recommended.

Mayer Brown's group is led by Jason Elder, and includes highly respected partners Billy Au and Jeckle Chiu. Equally strong in issuer- and underwriter-side work, the group excels in global offerings and Hong Kong listings, spin-offs, right issuances and various other equity capital markets transactions. In 2017, Au and senior associate Jeremy Hsu advised Risecomm Group Holdings on its $27m listing and global offering on the Main Board of the Hong Kong Stock Exchange. In addition, Au and Carmen Yuen assisted Jiayuan International Group with a placing of existing shares and subscription for new shares, which raised circa HK$1.18bn in gross proceeds. The team also advised the same client on a subsequent HK$1.4bn placing and top-up. Another highlight involved acting for China Overseas Land & Investment and China Overseas Property Holdings Limited (COPL) on COPL's spin-off and separate Hong Kong listing. The team also acts for issuers and underwriters on transactions further afield across Asia.

Morgan, Lewis & Bockius (in association with Luk & Partners)' equity capital markets offering underwent significant expansion in 2017, when the firm hired a team of lawyers from Orrick, Herrington & Sutcliffe LLP. One of these lawyers was Edwin Luk, who heads the capital markets practice in Asia, and is also global leader of the securities practice. Luk has led the strengthened team to complete nine Hong Kong IPOs in 2017 and, at the time of writing, two Hong Kong IPOs in 2018. During this period, three of these IPOs were in the top ten of the largest in Hong Kong, in terms of funds raised at completion. One of the matters saw Luk and Billy Wong acting as Hong Kong and US counsel to China Xinhua Education Group on its $168m Regulation S/Rule 144A Hong Kong Main Board IPO. Another highlight saw Luk and June Chan advise Guotai Junan Capital as sole sponsor on Ruifeng Power Group's $43m Hong Kong Main Board IPO. In 2017, Luk and Chan acted as Hong Kong and US counsel to Minsheng Education Group in its $178m Main Board IPO, which involved a Rule 144A international placement. In addition to advising on standalone listings in Hong Kong, the team has also become known for advising companies listed elsewhere internationally on dual listings in Hong Kong; a recent highlight involved advising Singapore Catalist Board-listed company LHN on its $10m Hong Kong Main Board dual listing. Elsewhere, other areas of activity have included secondary offerings and privatisations. Luk's team also includes practitioners such as Keith Cheung and Ning Zhang.

Morrison & Foerster has benefited from the synergy between its excellent track record in Hong Kong listings (and the entire ambit of capital markets transactions more generally) and its particularly strong reputation in the life sciences sector. Practice head Venantius Tan has led the team on a number of biotech transactions for clients such as GenScript Biotech, Jacobson Pharma, Fosun Pharma and Sinopharm. In addition, adding to the firm's credibility in the area, the group includes of counsel Yu Wang and associate Alex Cao, who hold Ph.D.s in scientific subjects. The firm also generates work involving other industries; in the consumer goods sector, Vivian Yiu and of counsel Samuel Ng recently acted for BOCI and BOSCI as joint sponsors in the circa $67.5m Hong Kong IPO of Tsit Wing. Another highlight saw Yiu advise PRC-based real estate developer Sunshine 100 China Holdings on a circa $93m share issuance to Huarong International Financial Holdings.

Cleary Gottlieb Steen & Hamilton's platform supports issuers and underwriters on complex listings and other offerings, including SEC-registered offerings and Regulation S/Rule 144A IPOs. Clients benefit from the firm's blend of Hong Kong, English and US law expertise. The team includes New York- and Hong Kong-qualified partner Shuang Zhao and counsel Robert Williams, who acted for iClick Interactive Asia Group on its $300m SEC-registered IPO and NASDAQ listing in 2017. Zhao was also the lead adviser to Credit Suisse and Citigroup as the lead bookrunners on the $271m SEC-registered IPO and New York Stock Exchange listing by PPDAI Group. Freeman Chan, who has nearly 30 years of Hong Kong capital markets experience, worked with Zhao, counsel Raymond Lam and others to advise JP Morgan, Credit Suisse, UBS and CMB International as joint sponsors and joint global coordinators on the $1.5bn Hong Kong IPO of ZhongAn Online Property and Casualty Insurance, along with a concurrent Regulation S/Rule 144A global offering. Jinko Solar, Bestway Global Holding and Lenovo Group are among other active clients. Chan and Zhao co-head the practice.

Eversheds Sutherland's global footprint makes it a strong choice for issuers seeking to list in Hong Kong and elsewhere in Asia, as well as for those looking to raise capital through public markets further afield, particularly in the US. Under the leadership of Stephen Mok, the team is particularly active in complex offerings including groundbreaking listings. Mok recently led a team that included Norman Hui and consultant Sin-Joh Chuang in advising Datang Power on its non-public issuance of A-shares to its controlling shareholder (China Datang Corporation, hereafter CDC), and also its non-public issuance of H-shares to a wholly owned subsidiary of CDC for circa $2.1bn; this marked the first time a whitewash waiver was used in Hong Kong for such issuances. Mok, Hui, Amy Yu and others acted as Hong Kong counsel to Precision Tsugami (China) on its $64m spin-off listing on the Main Board of the Hong Kong Stock Exchange; this listing was the first in Hong Kong to involve a spin-off from a Japanese company listed on the Tokyo Stock Exchange. In addition, Mok's team served as Hong Kong legal advisers to Nomura as the sole sponsor on Nissin Foods' circa $121m spin-off listing on the Main Board; this was the second listing in Hong Kong to involve a spin-off from a Japanese company listed on the Tokyo Stock Exchange. Beyond new listings and follow-on offerings, other work included Mok and others advising listed company New World Department Store (China) on its proposed privatisation by parent firm New World Development.

Although Jones Day is active in equity capital markets transactions involving traditional industries, such as financial services and infrastructure, it is experiencing a particularly significant uptick in work in more cutting-edge sectors, such as healthcare, life sciences, biotech and TMT. The firm's hire of Charles Chau from Morrison & Foerster in 2017 has been a particular boon to the practice, with it winning work from a number of new clients, including China Everbright Securities International, GenScript Biotech and CCB International Capital. The firm has particularly strong capabilities in equity transactions with a nexus to Japan, as was demonstrated when team head Joelle Lau and associates Terry Kwok and Halent Zhang acted for sole sponsor Halcyon Capital and a syndicate of underwriters on the Hong Kong Stock Exchange IPO of Precision Tsugami (China) as part of a spin-off by Tokyo-listed parent company Tsugami. Elsewhere, further showcasing the firm's cross-border work, Lau, Kwok and Zhang advised Evergreen Products Group, all of whose productions and operations are based in Bangladesh, on its $39m Hong Kong Stock Exchange IPO. Another highlight saw Lau and others assist Automated Systems Holdings with a HK$542m rights issuance and convertible bonds placement to facilitate its merger with Grid Dynamics International. Maria Pedersen  and associate Donna Ko are also recommended.

Milbank excels in high-profile and milestone offerings across Asia. In 2017, team head James Grandolfo led a team that included associates Kurtis Sherwood and Cesareo Singzon in acting for the underwriters on the $1.3bn IPO of SBI Life Insurance (a subsidiary of State Bank of India); this was the first billion-dollar IPO in India since 2010. In another headline mandate, Grandolfo, Asia counsel Paul Pery, Singzon and others recently advised BPI Capital and Maybank Kim Eng Securities as joint global coordinators and bookrunners on the $152m IPO of D.M. Wenceslao & Associates; this was the first IPO in the Phillipines in 2018, and the first international IPO out of the Philippines in nearly two years. Other clients include Axis Capital, Bank of America Merrill Lynch and Viet Capital.

Minter Ellison's 'organised, efficient' team combines a comprehensive understanding of the intricacies of capital raisings with regulatory expertise to advise mid-market Chinese and international corporates and entrepreneurs on their most complex requirements. It also has a strong sponsor-side practice. At the time of writing, its team, led by office managing partner Fred Kinmonth, is advising on ten Hong Kong IPOs. George Tong recently acted for Somerley Capital as sponsor on the £8m GEM IPO of Amasse Capital Holdings, while a team led by Anne Ko advised Innovax Capital as sponsor on MECOM Power and Construction's Main Board listing. Ko also acted for Oriental Capital (Hong Kong) as sponsor on the listing of Jiangsu Innovative Ecological New Materials. Other clients include Feishang Anthracite Resources, D&G Technology Holding and Parkson Retail Group. Barbara Mok and Katherine U  are recommended.

O'Melveny, which has an equally strong reputation among corporate issuers and financial institutions, has a varied workload of US IPOs, Hong Kong IPOs and a wide variety of secondary offerings, among other matters. It is particularly active in transactions connected with the life sciences and biotech space, and has been at the forefront of advice to clients seeking listings under the new chapter 18A of the Hong Kong Listing Rules. Edwin Kwok, counsel Lillian Cheung and members of the San Francisco office advised Shanghai-based drug development company Hua Medicine on its $110m IPO on the Main Board of the Hong Kong Stock Exchange; it is the third biotech company to complete an IPO under chapter 18A. Elsewhere, Kwok, and counsels Ke Huang and Ke Zhu acted for China Securities (International) Corporate Finance on the $300m IPO of online game publishing company FingerTango. In addition, the firm has a wider Indonesian and Southeast Asia equity capital markets practice, which is led by Andrew Hutton (who divides time between Hong Kong and Singapore).  Li Han recently joined from Shanda Group.

Reed Smith Richards Butler's market presence is illustrated by the fact that it has been involved in the listings of more than 260 companies out of 2,253 currently listed in Hong Kong to date. Its team is also vastly experienced in spin-offs, dual listings, secondary offerings (such as rights issues, placings and block trades) and privatisations of listed companies. Denise Jong, who leads the practice group in Asia, as well May Wong and Anthony Woo are names to note. The team's work also spans other industries, including telecoms, mining, gaming and logistics. Other key figures in the team are Michael Pepper, Delpha Ho, Ivy Lai and KC Mok.

Ropes & Gray LLP's practice is led by Victoria Lloyd, a fluent speaker of Mandarin, Cantonese and English with over two decades' experience undertaking the gamut of equity capital markets transactions. Lloyd's team acts for a wide range of market participants, including sovereign wealth funds, investment banks, private equity houses, and multinational corporates, on their most complex matters. Lloyd is advising Sun Hung Kai Financial as placing agent on a private placement, which involves the change of control and board composition of a Hong Kong-listed company. Lloyd is also assisting China-based private equity fund CMC with the pre-IPO structuring of one of its portfolio companies. Associate Irene Lau is also recommended.

Addleshaw Goddard, which is becoming 'increasingly prominent in the market', has been involved in 13 completed IPOs since 2016, on which it has acted for sponsors and underwriters. Clients highlight its team's 'business acumen, industry knowledge' and 'practical, effective advice'. Practice head Daniel Wan is 'easy to communicate with on legal points and issues'; his wide-ranging areas of expertise include pre-IPO restructurings and investments, Hong Kong IPOs, post-IPO regulatory and compliance, and secondary offerings. Clients include CMB International Capital, Haitong International Capital, Guotai Junan Capital and TC Capital Asia.

Baker McKenzie's team acts as Hong Kong and US legal counsel to sponsors and underwriters on the entire ambit of capital markets transactions. Its recent work included Christina Lee acting for Hong Kong Stock Exchange Main Board-listed company REXLot Holdings on a HK$25m rights issue. Lee also worked with Beijing-based Greater China practice head Jackie Lo to advise HNA Finance I and CCB International  Capital as the underwriters on the circa HK$9.25bn rights issuance by Hong Kong International Construction Investment Management Group in 2017. Another key figure in Hong Kong is Ivy Wong, who was the lead adviser to Everbright Grand China Assets on its $20m global offering and Hong Kong Main Board IPO. In addition to advising issuers and underwriters on IPOs and secondary offerings, the team also assists listed companies with compliance-related issues and public takeovers, among various other matters.

Howse Williams is particularly active in advising small- to mid-cap companies, as well as sponsors, on Hong Kong Stock Exchange listings; it completed 11 IPOs in 2017, and completed another three in the first quarter of 2018. Several of the listings handled by the firm involved companies with operations in Singapore and Malaysia. Brian Ho and Denise Che recently acted as Hong Kong counsel to Singapore-headquartered asset manager ZACD Group on its HK$160m global offering and GEM Board listing. The firm also advised on the IPOs of Chinese companies, including Morris Holdings, Trio Engineering and Wah Sun Handbags. Elsewhere, beyond IPOs, another highlight involved acting for China Oceanwide International Financial on a HK$5.1bn rights issuance. Other recommended practitioners are Chia Ching Tan, Chris Williams, Christopher Yu and Heidi Lee.

Kwok Yih & Chan acts for a broad base of clients, such as corporate issuers, listed companies, funds and investment banks. Its equity capital markets work is a cornerstone of the firm's broader corporate offering, with the firm assisting clients with Hong Kong Stock Exchange listings, secondary issuances, rights issuances, private placements and regulatory compliance, among other matters. In a recent mandate in the education sector, Larry Kwok and Leon Saw were among the advisers to Kingsley EduGroup on its HK$80m GEM Board listing. On the sponsor side, Dieter Yih, Cecil Kwong and others acted for KGI Capital Asia Limited on the circa HK$200m GEM Board IPO and listing of Ying Kee Tea House Group. Also recommended are Conrad Chan and consultants Denise Chan and Michelle Liu.

Stephenson Harwood has been an active player in the Greater China capital markets arena since the 1970s, and it significantly strengthened its offering recently by hiring a team of 11 fee-earners from Troutman Sanders LLP to its Beijing office. Allen Shyu, who led the group in the move across, divides time between his new firm's Beijing and Hong Kong offices, and handles Hong Kong and US capital markets transactions and regulatory issues. Paul Westover heads the practice, which covers a full spectrum of matters, including IPOs, secondary listings, dual listings and spin-off transactions. In a recent highlight, Anthony Chan and others acted as Hong Kong legal advisers to Zioncom Holdings on its GEM Board listing. In addition, Voon Keat Lai and Ivan Tan were part of a cross-office team that advised AIQ on its listing and admission on the Standard segment of the Main Market of the London Stock Exchange. Recently promoted partner Ivy Wong is also recommended.

Interview with...

Law firm partners and practice heads explain how their firms are adapting to clients' changing needs

International comparative guides

Giving the in-house community greater insight to the law and regulations in different jurisdictions.

Select Practice Area

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments in Hong Kong

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to